• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:黄武祯,陈斯宁,黎展华.参芪扶正注射液治疗慢性阻塞性肺疾病的理论与作用探析[J].药学研究,2024,43(10):989-994[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2989次   下载 2264次 本文二维码信息
码上扫一扫!
参芪扶正注射液治疗慢性阻塞性肺疾病的理论与作用探析
黄武祯1,陈斯宁1,黎展华2
字体:加大+|默认|缩小-
(1.广西中医药大学研究生院,广西 那宁 530001;2.广西中医药大学附属瑞康医院呼吸与危重症医学科,广西 南宁 530011)
摘要:
参芪扶正注射液是由党参、黄芪提取物组成的中药制剂,在治疗慢性阻塞性肺疾病(COPD)的临床研究中取得良好效果。本文旨在进一步阐明参芪扶正注射液治疗COPD的中医理论及其现代药理作用,以期为参芪扶正注射液的临床合理应用提供理论依据,为进一步临床和实验研究提供思路。本文通过文献回顾、理论分析等方法探讨在COPD的治疗中运用“补肺健脾法”的理论依据,分析参芪扶正注射液“补肺健脾”功效与药理作用关系、临床意义以及药物警戒。通过本次探析得出以下结论:①肺脾气虚是慢阻肺疾病发展中的重要病机,可用“健脾补肺法”治疗。②参芪扶正注射液具有“补肺健脾”功效,适用于肺脾气虚证COPD患者。其传统功效的科学内涵与调节免疫、保护肺组织、改善消化吸收功能等药理作用相关。③参芪扶正注射液在COPD的应用中具有提高临床疗效,改善临床症状、肺功能、炎症指标及免疫功能等临床意义。④参芪扶正注射液的应用须注意遵循中医辨证论治原则,避免因证型误用产生不良反应。
关键词:  参芪扶正注射液  慢性阻塞性肺疾病  作用机制  补肺健脾法  临床疗效
DOI:10.13506/j.cnki.jpr.2024.10.011
基金项目:国家自然科学基金项目(No.82360908)
出版日期:2024-10-30
Exploring the theory and effect of Shenqi Fuzheng Injection in the treatment of chronic obstructive pulmonary disease
HUANG Wuzhen1,CHEN Sining1,LI Zhanhua2
(1. Graduate School of Guangxi University of Traditional Chinese Medicine, Nanning 530000, China; 2. Department of Respiratory and Critical Care, Ruikang Hospital Affiliated to Guangxi University of Traditional Chinese Medicine, Nanning 530000, China)
Abstract:
Shenqi Fuzheng Injection is a traditional Chinese medicine preparation composed of Codonopsis pilosula and Astragalus membranaceus extract, which has achieved good results in the clinical study of chronic obstructive pulmonary disease(COPD). The purpose of this paper is to further clarify the traditional Chinese medicine theory and modern pharmacological effects of Shenqi Fuzheng Injection in the treatment of chronic obstructive pulmonary disease, in order to provide a theoretical basis for the clinical rational application of Shenqi Fuzheng Injection, and to provide ideas for further clinical and experimental research. In this paper, through literature review, theoretical analysis and other methods to explore the theoretical basis of the use of ' Bufei Jianpi method ' in the treatment of COPD, analysis of Shenqi Fuzheng injection ' Bufei Jianpi ' efficacy and pharmacological effects of the relationship, clinical significance and pharmacovigilance.Through this analysis, the following conclusions are drawn: ① Lung and spleen qi deficiency is an important pathogenesis in the development of chronic obstructive pulmonary disease, which can be treated by “invigorating spleen and tonifying lung method”. ②Shenqi Fuzheng Injection has the effect of “tonifying lung and invigorating spleen”, which is suitable for patients with chronic obstructive pulmonary disease of lung and spleen qi deficiency syndrome. The scientific connotation of its traditional efficacy is related to pharmacological effects such as regulating immunity, protecting lung tissue, and improving digestion and absorption function. ③Shenqi Fuzheng Injection has clinical significance in improving clinical efficacy, clinical symptoms, lung function, inflammatory index and immune function in the application of COPD. ④The application of Shenqi Fuzheng Injection should follow the principle of syndrome differentiation and treatment of traditional Chinese medicine to avoid adverse reactions caused by misuse of syndrome types.
Key words:  Shenqi Fuzheng Injection  Chronic obstructive pulmonary disease  Mechanism of action  Tonifying lung and invigorating spleen method  Clinical efficacy
今日访问量:2493    总访问量:55338936
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司